Richard D. Klausner, M.D., officially stepped down as the director of the National Cancer Institute (NCI) on Friday, Sept. 28. Klausner was recently named president of the newly created Case Institute of Health, Science and Technology, which will be located in Washington, D.C.

Richard D. Klausner, M.D., announced today that he plans to step down from his post as director of the National Cancer Institute (NCI) at the National Institutes of Health (NIH) on Sept. 30. “It has been a privilege and an honor to head one of the world’s great scientific institutions dedicated to the advancement and […]

The National Cancer Institute (NCI) and the American College of Radiology Imaging Network (ACRIN) are launching the first large, multicenter study to compare digital mammography to standard mammography for the detection of breast cancer.

Green Auditorium, NIST Administration Bldg. (Bldg. 101), Gaithersburg, Md.
The Commerce Departments National Institute of Standards and Technology and the National Institutes of Healths National Cancer Institute invite reporters to learn how the smallest of technological soldiers are being enlisted in the fight against one of the worlds biggest health problems, cancer.

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, sponsored by the National Cancer Institute (NCI), reached a significant milestone last month with the enrollment of its final participant.

Scientists report today in the New England Journal of Medicine* that 11 of 13 patients with hairy cell leukemia, a cancer of the immune system, had complete remissions after receiving adequate treatment with the recombinant immunotoxin BL22. A recombinant immunotoxin is an antibody that has been bioengineered to recognize and directly deliver a deadly toxin […]

1. What was the purpose of the study?
There is clear evidence that use of oral contraceptives (birth control pills) reduces the risk of ovarian cancer in the general population. The purpose of the current study was to evaluate whether the use of oral contraceptives reduces the risk of ovarian cancer in women with specific alterations […]

Healthy men age 55 and older are needed for the largest-ever prostate cancer prevention study, launched today by the National Cancer Institute (NCI) and a network of researchers known as the Southwest Oncology Group (SWOG). The Selenium and Vitamin E Cancer Prevention Trial, or SELECT, will determine if these two dietary supplements can protect against […]

The Food and Drug Administration (FDA) and the National Cancer Institute (NCI) announced today a new joint research and clinical program that holds great promise for developing better and more targeted treatments for cancer.
The new program, called the Clinical Proteomics Program, melds the study of all proteins in living cells (or proteomics) to the clinical […]

Researchers have found that the survival rates for two alternative treatments for primary eye cancer - radiation therapy and removal of the eye - are about the same. Prior to this finding, there was a question in the medical community as to whether either treatment might result in lower mortality. Also, as a consequence of […]